CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Dyne Therapeutics stock slips after pricing upsized $375M public offering at $20.50 per share

Negative
AI Analysis

Summary

Dyne Therapeutics priced an upsized $375M public offering at $20.50 per share, with stock declining following the announcement.

Importance:5/10
Sentiment:
-0.30
capital_raisepublic_offeringequity_financing
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 22, 2026 6:45 AM

Read Original